9 stories
The UK’s medical regulator has officially approved a new pharmaceutical option for weight management, marking a pivotal shift in the nation's public health strategy. This development offers a fresh al...
The rise of GLP-1 medications has sparked a worldwide frenzy, blurring the lines between medical necessity and cosmetic trends. We explore how the scramble for semaglutide is reshaping our approach to...
As GLP-1 weight loss drugs take the world by storm, a significant side effect—muscle loss—is becoming impossible to ignore. New pharmaceutical breakthroughs aim to preserve lean mass, ensuring that th...
Forget the old willpower debate. New weight-loss drugs like Wegovy and Mounjaro are targeting the brain’s hormonal signals to turn down the volume on hunger and reshape metabolic health.
Weight-loss injections like Wegovy and Mounjaro have been hailed as miracle cures, but their results are far from uniform. We dive into the biological and genetic reasons why these medications deliver...
Weight-loss injections have dominated health headlines, but new research suggests their effectiveness isn't one-size-fits-all. We break down the latest findings on how these medications impact differe...
A recent File on 4 investigation dives deep into the meteoric rise of weight loss injections, uncovering the health risks and systemic pressures lurking behind the miracle headlines. From supply short...
Pharmaceutical giant Novo Nordisk is set to debut a significant commercial for its weight-loss drug, Wegovy, during the Super Bowl, aiming to reach millions of viewers. This high-profile advertisement...
Regulators are issuing updated safety warnings concerning a rare but severe risk of pancreatitis associated with widely used GLP-1 receptor agonist weight loss injections. Patients and healthcare prov...
